A Phase 1 Double-Blind Crossover Comparative Study of Neurofeedback for the Treatment of Parkinson's Disease

Osaka University1 site in 1 country20 target enrollmentJune 1, 2019

ConditionsParkinson Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Parkinson Disease
Sponsor: Osaka University
Enrollment: 20
Locations: 1
Primary Endpoint: Alteration of Brain Activities
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study aims to reveal relationship between brain activities and the symptoms of Parkinson disease when a neurofeedback training was applied for them.

Registry

clinicaltrials.gov

Start Date

June 1, 2019

End Date

March 31, 2022

Last Updated

6 years ago

Study Type

Interventional

Study Design

Crossover

Sex

All

Investigators

Sponsor

Osaka University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Subjects with age more than 20
•Subjects obtained the consent
•Subjects with Parkinson disease and healthy subjects

Exclusion Criteria

•The subjects who can not conduct the tasks
•Subjects with severe illness
•Subjects whom the experimenter think as in appropriate
•Subjects with implantable devices such as pacemaker

Outcomes

Primary Outcomes

Alteration of Brain Activities

Time Frame: At the time Immediately following the training

measured by magnetoencephalography

Secondary Outcomes

The raw score change from baseline in the Movement disorder society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part Ⅲ scores(At the time Immediately following the training)